Tang Capital Management Llc - Apr 24, 2025 SCHEDULE 13G Report for Spyre Therapeutics, Inc. Common Stock, par value $0.0001 per share (SYRE)

Filing Manager
TANG CAPITAL MANAGEMENT LLC
Reporting Manager
TANG CAPITAL MANAGEMENT, LLC
Security
Spyre Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
SYRE
Shares outstanding
60.4M shares
Disclosed Ownership
3.2M shares
Ownership
5.3%
Form type
SCHEDULE 13G
Date filed
5/1/2025, 04:15 PM
Date of event
Apr 24, 2025
SEC
View on sec.gov

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
TANG CAPITAL MANAGEMENT, LLC 5.3% 3.2M 0 3.2M /s/ Kevin Tang Manager
KEVIN TANG 5.3% 3.2M 0 3.2M /s/ Kevin Tang Self
TANG CAPITAL PARTNERS, LP 3% 1.8M 0 1.8M /s/ Kevin Tang Manager, Tang Capital Management, LLC, General Partner
TANG CAPITAL PARTNERS INTERNATIONAL, LP 2.3% 1.4M 0 1.4M /s/ Kevin Tang Manager, Tang Capital Management, LLC, General Partner
TANG CAPITAL PARTNERS III, INC 0% 0 0 0 /s/ Kevin Tang Chief Executive Officer
TANG CAPITAL PARTNERS IV, INC 0% 0 0 0 /s/ Kevin Tang Chief Executive Officer